Home Front Page

Latest News

Increased Risk of Cardiac Events Identified in Patients With Multiple Sclerosis

Lower Dose of Cabozantinib Fails to Meet Primary Endpoint in MTC Trial

A Rare Case of Cold Agglutinin Disease Induced by COVID-19

BRD9 as a Novel Therapeutic Potential for GIST

SERPINA1 Genotypes Pose Different Risks for Liver Pathology

Alagille Syndrome May Alter the Microvasculature

Dr. Naftali Kaminski Discusses New Consortium for Pulmonary Fibrosis

Local Anesthesia Better for Pregnant PAH Patients

Potential New Biomarker Could Predict NMOSD Prognosis

Direct-to-Consumer Genomic Testing May Help Identify AATD

Case Report: A Rare Co-occurrence of ALGS and Von Willebrand Disease

Male Sex Associated With Poor Prognosis in GIST

PPIs Associated With Increased Risk of Developing Autoimmune Diseases

FDA Chief Janet Woodcock: ‘We Have a Long Way to Go’ in Rare Disease

Repository for DMD and BMD Introduced at NORD Breakthrough Summit

Latest Features

New Venture Aims to Improve Diagnosis, Treatment of Pulmonary Fibrosis

Three Lakes Foundation, Yale University, and the University of Pittsburgh are joining forces to speed up the search for treatments for pulmonary fibrosis.
The Association Between Cold Agglutinin Disease and Thromboembolic Events

There are a few things that physicians do their best to avoid when a patient is under their care. One of the most basic things to check, for example, is the patient’s allergy status to avoid needless drug reactions that can sometimes be life-threatening. Another thing that is always on a physician’s mind is the…
A Look at the Genetic Landscape in Pompe Disease

In Pompe disease, the mutational landscape and the amount of AAG activity determine the disease severity, tissue impairment, and age of onset.